Darunavir

d[Leu⁴]AVP.

d[Leu⁴]AVP.

Biochem/physiol Actions Darunavir has been sanctioned by the food and drug administration (FDA) as the first treatment of drug-resistant human immunodeficiency virus (HIV). Darunavir is a second-generation antiviral HIV protease inhibitor with

Biochem/physiol Actions Darunavir has been sanctioned by the food and drug administration (FDA) as the first treatment of drug-resistant human immunodeficiency virus (HIV). Darunavir is a second-generation antiviral HIV protease inhibitor with

Darunavir

Darunavir

A second generation protease inhibitor that supresses the replication of various strains of HIV-1 (IC₅₀s = 3-30 nM) inhibits both cell-free diffusion and cell-to-cell spread of HIV-1 with IC₅₀ values of 2.5 and 2.

A second generation protease inhibitor that supresses the replication of various strains of HIV-1 (IC₅₀s = 3-30 nM) inhibits both cell-free diffusion and cell-to-cell spread of HIV-1 with IC₅₀ values of 2.5 and 2.

A second generation protease inhibitor that supresses the replication of various strains of HIV-1 (IC₅₀s = 3-30 nM) inhibits both cell-free diffusion and cell-to-cell spread of HIV-1 with IC₅₀ values of 2.5 and 2.

Rappaport Vassiliadis R10 Medium, 2.5KG

Rappaport Vassiliadis R10 Medium, 500G

Rappaport Vassiliadis R10 Medium, 5KG